Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity
Saved in:
| Published in: | PLOS Global Public Health |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Tiered manufacturing of pharmaceuticals as a commercial determinant of health: Implications for medicine quality and equity
- Advancing Health Equity in the US Military
- Fraud and Abuse Law: Missed Opportunities to Enhance Health Equity
- How the Nurse-Led Model of Care Reimbursement Gap Undermines Health Equity
- Reforming competitive global public health funding: Bridging equity and practice gaps
- Be Careful What You Wish For: An Overreliance on Telemedicine Could Harm Health Equity
- Supporting Minority Serving Institution Faculty to Enhance Biomedical Research: The CSULB Center for Health Equity Research Institute
